IMA
insider transactionsImageneBio, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
+721.3K
721.3K buy · 0 sell
Net value · 90d
$0
$0 in · $0 out
Sentiment · 90d
Net buying
0% buying · 0% selling
Open-market trades · 90d
2
721.3K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
15.6K sh
Own New
-
Grant·A
Director
$0
15.6K sh
Own New
-
Grant·A
Director
$0
15.6K sh
Own New
-
Buy·P
—
384.7K sh
Own New
-
Buy·P
—
336.6K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Jonathan Jian Wang | Grant A | 15.6K | $0 |
| Jun 16, 2026 | Otello Stampacchia | Grant A | 15.6K | $0 |
| Jun 16, 2026 | Joseph P Slattery | Grant A | 15.6K | $0 |
| Apr 14, 2026 | ORBIMED ADVISORS LLC / OrbiMed Capital GP VI LLC / OrbiMed Genesis GP LLC | Buy P | 384.7K | — |
| Apr 14, 2026 | ORBIMED ADVISORS LLC / OrbiMed Capital GP VI LLC / OrbiMed Genesis GP LLC | Buy P | 336.6K | — |
About IMA insider trading
This page tracks insider transactions for ImageneBio, Inc. (IMA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.